United States
Germany
Japan
United Kingdom
China
SLA2 mouse monoclonal antibody, clone OTI3A7 (formerly 3A7)
| Applications | FC, IHC, WB |
| Reactivities | Human |
Products
SLA2 mouse monoclonal antibody, clone OTI1F7 (formerly 1F7)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI3E3 (formerly 3E3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI2G3 (formerly 2G3)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
SLA2 (Myc-DDK-tagged)-Human Src-like-adaptor 2 (SLA2), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
SLA2 mouse monoclonal antibody, clone OTI1E7 (formerly 1E7)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI3A7 (formerly 3A7)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLA2 (Myc-DDK-tagged)-Human Src-like-adaptor 2 (SLA2), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
SLA2 mouse monoclonal antibody, clone OTI4A11 (formerly 4A11)
| Applications | IHC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI1D8 (formerly 1D8)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody,clone OTI2B2
| Applications | IHC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI1D2 (formerly 1D2)
| Applications | FC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI2F7 (formerly 2F7)
| Applications | FC, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI3D4 (formerly 3D4)
| Applications | IF, WB |
| Reactivities | Human |
SLA2 mouse monoclonal antibody, clone OTI3H9 (formerly 3H9)
| Applications | IF, WB |
| Reactivities | Human |
